Table 3.
Outcomes of treatment of pulmonary actinomycosis with various oral antibiotics
| |
All patients (n = 68) |
Initial antibiotics alone (n = 53) |
||||||
|---|---|---|---|---|---|---|---|---|
| Cured | Failure | Relapse | Total | Cured | Failure | Relapse | Total | |
| AMX-CLV |
27 (90.0) |
3 (10.0) |
0 (0) |
30 |
25 (89.3) |
3 (10.7) |
0 (0.0) |
28 |
| AMP-SUL |
20 (80.0) |
2 (8.0) |
3 (12.0) |
25 |
10 (71.5) |
1 (7.1) |
3 (21.4) |
14 |
| Amoxicillin |
4 (80.0) |
1 (20.0) |
0 (0) |
5 |
3 (75.0) |
1 (25.0) |
0 (0) |
4 |
| Ampicillin |
2 (100) |
0 (0) |
0 (0) |
2 |
2 (100) |
0 (0) |
0 (0) |
2 |
| Clindamycin |
3 (100) |
0 (0) |
0 (0) |
3 |
2 (100) |
0 (0) |
0 (0) |
2 |
| Others | 3 (100) | 0 (0) | 0 (0) | 3 | 3 (100) | 0 (0) | 0 (0) | 3 |
AMX-CLV; Amoxicillin clavulanate.
AMP-SUL; Ampicillin sulbactam.